Our current tissue annotation efforts have been on increasing the breadth and depth of the tissue effort first started in ChEMBL 22. The figure above represents the increased depth and coverage from that initial point till now. We continue to use a suite of tissue ontologies namely: Uberon, Experimental Factor Ontology ( http://www.ebi.ac.uk/ols/ontologies/efo ) , CALOHA (ftp://ftp.nextprot.org/pub/current_release/controlled_vocabularies/caloha.obo) and Brenda Tissue Ontology ( ( http://www.ebi.ac.uk/ols/ontologies/bto ) to identify assays where the tissue is the assay system. We have increased the detail of information we capture to reflect the more granular tissues mentioned in the assays such as 'Popliteal lymph node' and 'Substantia nigra' pars compacta where previously the higher level term ‘lymph node’ and ‘Substantia nigra’ might have been captured. Plasma based assays We have recently focused annotation efforts on plasma bas...
The Organization of Drug Discovery Data
| | | | | | | |